ME

MEDINET Co., Ltd.

A CDMO for cell therapy and regenerative medicine development & manufacturing.

2370 | T

Overview

Corporate Details

ISIN(s):
JP3920990003
LEI:
Country:
Japan
Address:
品川区勝島一丁目5番21号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MEDINET Co., Ltd. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the regenerative medicine and cell therapy sectors. Since its establishment in 1999, the company has provided comprehensive, one-stop solutions across the entire value chain, from pre-clinical research and technology transfer to manufacturing and commercial launch. Key services include process development, quality control, quality assurance, and logistics. MEDINET operates an advanced cell processing facility compliant with Japanese, US, and European GCTP standards, leveraging its extensive experience and deep expertise in Japan's regulatory framework to support its clients' development and manufacturing needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 08:33
Report Publication Announcement
確認書
Japanese 8.3 KB
2025-05-14 08:32
Interim / Quarterly Report
半期報告書-第30期(2024/10/01-2025/09/30)
Japanese 204.7 KB
2024-12-26 04:04
AGM Information
臨時報告書
Japanese 25.2 KB
2024-12-18 07:40
Registration Form
確認書
Japanese 8.3 KB
2024-12-18 07:38
Governance Information
内部統制報告書-第29期(2023/10/01-2024/09/30)
Japanese 21.6 KB
2024-12-18 07:35
Annual Report
有価証券報告書-第29期(2023/10/01-2024/09/30)
Japanese 1.3 MB
2024-05-14 08:02
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-05-14 08:00
Quarterly Report
四半期報告書-第29期第2四半期(2024/01/01-2024/03/31)
Japanese 200.2 KB
2024-02-13 07:04
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-02-13 07:01
Quarterly Report
四半期報告書-第29期第1四半期(2023/10/01-2023/12/31)
Japanese 152.4 KB
2023-12-21 07:03
Registration Form
確認書
Japanese 8.3 KB
2023-12-21 07:02
Governance Information
内部統制報告書-第28期(2022/10/01-2023/09/30)
Japanese 21.7 KB
2023-12-21 07:01
Annual Report
有価証券報告書-第28期(2022/10/01-2023/09/30)
Japanese 1.3 MB
2023-08-10 08:02
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-08-10 08:00
Quarterly Report
四半期報告書-第28期第3四半期(2023/04/01-2023/06/30)
Japanese 157.7 KB

Automate Your Workflow. Get a real-time feed of all MEDINET Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MEDINET Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MEDINET Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland
MAB
MACROGENICS INC Logo
Biopharma firm developing innovative antibody-based therapeutics for cancer treatment.
United States of America
MGNX
MADRIGAL PHARMACEUTICALS, INC. Logo
Develops and delivers the first FDA-approved treatment for the liver disease MASH.
United States of America
MDGL
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden
MAGLE
MAIA Biotechnology, Inc. Logo
Developing telomere-targeting immuno-oncology therapies for difficult-to-treat cancers.
United States of America
MAIA
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany
MYNZ
MANNKIND CORP Logo
Develops inhaled therapies for endocrine, orphan lung, and cardiometabolic diseases.
United States of America
MNKD
MARAVAI LIFESCIENCES HOLDINGS, INC. Logo
Provides nucleic acid products and biologics safety testing for new therapies and vaccines.
United States of America
MRVI
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria
MARI
Marker Therapeutics, Inc. Logo
Developing non-genetically modified T cell immunotherapies for hematologic and solid tumors.
United States of America
MRKR

Talk to a Data Expert

Have a question? We'll get back to you promptly.